The HSPB1 Knockout HEK293T Polyclonal Cells represent a CRISPR/Cas9-edited population of human embryonic kidney cells with targeted disruption of the HSPB1 gene. Derived from the extensively characterized HEK293T cell line, this polyclonal knockout pool provides a heterogeneous loss-of-function model for investigating the molecular chaperone HSPB1 (Hsp27) in cellular stress responses, apoptotic regulation, and actin-based dynamics. The polyclonal format, produced without single-cell cloning, minimizes clonal artifacts and enables robust assessment of HSPB1-dependent phenotypes in a genetically diverse context, making it well-suited for pathway dissection, drug screening, and functional genomics.
The HEK293T host cell line stably expresses the SV40 large T antigen, which drives episomal replication of plasmids containing the SV40 origin, thereby amplifying protein production. Known for high transfection efficiency and rapid growth, HEK293T cells are a versatile workhorse for recombinant protein expression, lentivirus production, and transient signaling assays. Their inherent activation of MAPK and Akt signaling cascades presents a physiologically relevant background for probing HSPB1??s regulatory roles in stress-response and survival networks.
HSPB1 is an ATP-independent molecular chaperone that prevents aggregation of denatured proteins under conditions of heat shock, oxidative stress, and inflammatory cytokines. Its function is tightly regulated by phosphorylation via the p38 MAPK?CMAPKAPK2/3 kinase module, which is stimulated by upstream signals such as TNF-?? and IL-1. Once phosphorylated, HSPB1 binds cytochrome c and suppresses apoptosome formation, thereby inhibiting caspase-3-mediated apoptosis. Additionally, HSPB1 interacts with Akt and influences the phosphorylation of BAD and the IKK complex, connecting chaperone activity to survival signaling and NF-??B activation. Through direct association with F-actin, HSPB1 modulates cytoskeletal stability, and interactions with Daxx and PCNA integrate its chaperone role with transcriptional regulation and DNA repair processes.
In the HEK293T cellular context, HSPB1 ablation removes a key node in the interplay between stress kinases and survival pathways, rendering cells more vulnerable to apoptosis and disrupting actin-dependent processes such as migration and adhesion. This knockout model permits rigorous dissection of the crosstalk between p38-MAPKAPK2 and Akt signaling on apoptotic effectors and cytoskeletal dynamics. The exceptional transfectability of HEK293T cells further enables rescue experiments and structure?Cfunction analyses of HSPB1 phosphorylation mutants, facilitating systematic mapping of functional domains.
Researchers can employ this cell pool in a comprehensive array of assays: Western blotting for total and phospho-HSPB1 confirms target disruption and monitors stress-induced phosphorylation; caspase-3 activity and TUNEL staining quantify apoptosis; immunofluorescence and phalloidin labeling reveal actin remodeling; co-immunoprecipitation captures HSPB1 complexes with Akt, caspase-3, or p38; and scratch wound-healing or transwell migration assays evaluate cell motility. These applications position the HSPB1 Knockout HEK293T Polyclonal Cells as a strategic tool for studies in cancer invasion, neurodegenerative protein aggregation, cardiovascular stress responses, and drug resistance mechanisms. For technical inquiries, please contact Ascent Research.
